These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 8630925

  • 1. Prognostic value of ploidy and proliferation markers in renal cell carcinoma.
    Tannapfel A, Hahn HA, Katalinic A, Fietkau RJ, Kühn R, Wittekind CW.
    Cancer; 1996 Jan 01; 77(1):164-71. PubMed ID: 8630925
    [Abstract] [Full Text] [Related]

  • 2. Apoptosis and proliferation in relation to histopathological variables and prognosis in hepatocellular carcinoma.
    Tannapfel A, Geissler F, Köckerling F, Katalinic A, Hauss J, Wittekind C.
    J Pathol; 1999 Mar 01; 187(4):439-45. PubMed ID: 10398104
    [Abstract] [Full Text] [Related]

  • 3. [Prognostic significance of proliferation markers in hepatocellular carcinoma (HCC)].
    Ebelt J, Neid M, Tannapfel A, Witzigmann H, Hauss J, Köckerling F, Wittekind C.
    Zentralbl Chir; 2000 Mar 01; 125(7):597-601. PubMed ID: 10960968
    [Abstract] [Full Text] [Related]

  • 4. Incidence of apoptosis, cell proliferation and P53 expression in renal cell carcinomas.
    Tannapfel A, Hahn HA, Katalinic A, Fietkau RJ, Kühn R, Wittekind CW.
    Anticancer Res; 1997 Mar 01; 17(2A):1155-62. PubMed ID: 9137464
    [Abstract] [Full Text] [Related]

  • 5. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
    Cheville JC, Zincke H, Lohse CM, Sebo TJ, Riehle D, Weaver AL, Blute ML.
    Cancer; 2002 Apr 15; 94(8):2180-4. PubMed ID: 12001115
    [Abstract] [Full Text] [Related]

  • 6. Prognostic significance of ploidy, MIB-1 proliferation marker, and p53 in renal cell carcinoma.
    Kramer BA, Gao X, Davis M, Hall M, Holzbeierlein J, Tawfik O.
    J Am Coll Surg; 2005 Oct 15; 201(4):565-70. PubMed ID: 16183495
    [Abstract] [Full Text] [Related]

  • 7. Prognostic implication of proliferative markers MIB-1 and PC10 in esophageal squamous cell carcinoma.
    Lam KY, Law SY, So MK, Fok M, Ma LT, Wong J.
    Cancer; 1996 Jan 01; 77(1):7-13. PubMed ID: 8630942
    [Abstract] [Full Text] [Related]

  • 8. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
    Larsson P.
    Scand J Urol Nephrol Suppl; 1994 Jan 01; 165():1-48. PubMed ID: 7871395
    [Abstract] [Full Text] [Related]

  • 9. The superior prognostic value of humoral factors compared with molecular proliferation markers in renal cell carcinoma.
    Lehmann J, Retz M, Nürnberg N, Schnöckel U, Raffenberg U, Krams M, Kellner U, Siemer S, Weichert-Jacobsen K, Stöckle M.
    Cancer; 2004 Oct 01; 101(7):1552-62. PubMed ID: 15378494
    [Abstract] [Full Text] [Related]

  • 10. Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index.
    Khine MM, Aung W, Sibbons PD, Howard CV, Clapham E, McGill F, Van Velzen D.
    Lab Invest; 1994 Jan 01; 70(1):125-9. PubMed ID: 7905542
    [Abstract] [Full Text] [Related]

  • 11. Proliferating cell nuclear antigen (PCNA) expression as a prognostic indicator for renal cell carcinoma: comparison with tumour grade, mitotic index, and silver-staining nucleolar organizer region numbers.
    Delahunt B, Bethwaite PB, Nacey JN, Ribas JL.
    J Pathol; 1993 Aug 01; 170(4):471-7. PubMed ID: 8105046
    [Abstract] [Full Text] [Related]

  • 12. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
    Oyama T, Osaki T, Nose N, Ichiki Y, Inoue M, Imoto H, Yoshimatsu T, Kodate M, Uramoto H, Mizoue T, Yano K, Yasumoto K.
    Anticancer Res; 2000 Aug 01; 20(1B):505-10. PubMed ID: 10769714
    [Abstract] [Full Text] [Related]

  • 13. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
    Tanioka F, Hiroi M, Yamane T, Hara H.
    Zentralbl Pathol; 1993 Aug 01; 139(3):185-93. PubMed ID: 8105885
    [Abstract] [Full Text] [Related]

  • 14. Use of proliferative markers Ki-67 (MIB-1) and proliferating cell nuclear antigen (PC10) in transitional cell carcinoma of the renal pelvis.
    Cheville JC, Terrell RB, Cohen MB.
    Mod Pathol; 1994 Sep 01; 7(7):794-800. PubMed ID: 7824516
    [Abstract] [Full Text] [Related]

  • 15. [Usefulness of DNA ploidy, AgNORs, PCNA and c-erbB-2 as predictors of prognosis in patients with renal cell carcinoma].
    Tamaki M, Maeda S, Deguchi T, Kawada Y.
    Hinyokika Kiyo; 1997 Oct 01; 43(10):697-702. PubMed ID: 9395903
    [Abstract] [Full Text] [Related]

  • 16. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
    Crucitti A, Masetti R, Breccia C, Coppola R, Magistrelli P, Nuzzo G, Maggiano N, Picciocchi A.
    Hepatogastroenterology; 1999 Oct 01; 46(26):1187-91. PubMed ID: 10370689
    [Abstract] [Full Text] [Related]

  • 17. Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct.
    Suto T, Sugai T, Nakamura S, Funato O, Nitta H, Sasaki R, Kanno S, Saito K.
    Cancer; 1998 Jan 01; 82(1):86-95. PubMed ID: 9428483
    [Abstract] [Full Text] [Related]

  • 18. The expression of thrombospondin-1 and p53 in clear cell renal cell carcinoma: its relationship to angiogenesis, cell proliferation and cancer specific survival.
    Zubac DP, Bostad L, Kihl B, Seidal T, Wentzel-Larsen T, Haukaas SA.
    J Urol; 2009 Nov 01; 182(5):2144-9. PubMed ID: 19758660
    [Abstract] [Full Text] [Related]

  • 19. The prognostic value of p53 nuclear overexpression and MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder.
    Popov Z, Hoznek A, Colombel M, Bastuji-Garin S, Lefrere-Belda MA, Bellot J, Abboh CC, Mazerolles C, Chopin DK.
    Cancer; 1997 Oct 15; 80(8):1472-81. PubMed ID: 9338472
    [Abstract] [Full Text] [Related]

  • 20. Proliferative activity is a significant prognostic factor in male breast carcinoma.
    Pich A, Margaria E, Chiusa L.
    Am J Pathol; 1994 Aug 15; 145(2):481-9. PubMed ID: 7519830
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.